Editorial: paradoxical skin lesions during anti ‐TNF treatment—an additional argument to consider new biologics as first‐line therapy in inflammatory bowel disease. Authors’ reply

Alimentary Pharmacology&Therapeutics,Volume 48, Issue 6, Page 684-685, September 2018.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Source Type: research